136 related articles for article (PubMed ID: 16635739)
21. Absence of a pharmacokinetic interaction between etanercept and warfarin.
Zhou H; Patat A; Parks V; Buckwalter M; Metzger D; Korth-Bradley J
J Clin Pharmacol; 2004 May; 44(5):543-50. PubMed ID: 15102876
[TBL] [Abstract][Full Text] [Related]
22. Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin.
Schwartz JI; Dunbar S; Yuan J; Li S; Gipson A; Rosko K; Johnson-Levonas AO; Lasseter KC; Addy C; Stoch AS; Wagner JA
Adv Ther; 2008 Nov; 25(11):1175-90. PubMed ID: 18989636
[TBL] [Abstract][Full Text] [Related]
23. Curcumin alters the pharmacokinetics of warfarin and clopidogrel in Wistar rats but has no effect on anticoagulation or antiplatelet aggregation.
Liu AC; Zhao LX; Lou HX
Planta Med; 2013 Jul; 79(11):971-7. PubMed ID: 23807811
[TBL] [Abstract][Full Text] [Related]
24. Acute effects of griseofulvin on the pharmacokinetics and pharmacodynamics of warfarin in rats.
Matsumura Y; Yokota M; Yoshioka H; Shibata S; Ida S; Takiguchi Y
J Int Med Res; 1999; 27(4):167-75. PubMed ID: 10599028
[TBL] [Abstract][Full Text] [Related]
25. Effect of tolterodine on the anticoagulant actions and pharmacokinetics of single-dose warfarin in healthy volunteers.
Rahimy M; Hallén B; Narang P
Arzneimittelforschung; 2002; 52(12):890-5. PubMed ID: 12572529
[TBL] [Abstract][Full Text] [Related]
26. Prevention of common colds with Andrographis paniculata dried extract. A Pilot double blind trial.
Cáceres DD; Hancke JL; Burgos RA; Wikman GK
Phytomedicine; 1997 Jun; 4(2):101-4. PubMed ID: 23195395
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
Modi NB; Kell S; Simon M; Vargas R
J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Kan Jang
Ratiani L; Pachkoria E; Mamageishvili N; Shengelia R; Hovhannisyan A; Panossian A
Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015163
[TBL] [Abstract][Full Text] [Related]
29. Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts.
Alnaqeeb M; Mansor KA; Mallah EM; Ghanim BY; Idkaidek N; Qinna NA
BMC Complement Altern Med; 2019 Jan; 19(1):29. PubMed ID: 30678660
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin.
Zhou L; Wang S; Zhang Z; Lau BS; Fung KP; Leung PC; Zuo Z
J Ethnopharmacol; 2012 Sep; 143(2):648-55. PubMed ID: 22867637
[TBL] [Abstract][Full Text] [Related]
31. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
[TBL] [Abstract][Full Text] [Related]
32. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
Gu N; Kim BH; Lim KS; Kim SE; Nam WS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
[TBL] [Abstract][Full Text] [Related]
33. Bisoprolol: studies of potential interactions with theophylline and warfarin in healthy volunteers.
Warrington SJ; Johnston A; Lewis Y; Murphy M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S164-8. PubMed ID: 11527121
[TBL] [Abstract][Full Text] [Related]
34. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Kan Jang
Ratiani L; Pachkoria E; Mamageishvili N; Shengelia R; Hovhannisyan A; Panossian A
Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765004
[No Abstract] [Full Text] [Related]
36. Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever.
Amaryan G; Astvatsatryan V; Gabrielyan E; Panossian A; Panosyan V; Wikman G
Phytomedicine; 2003 May; 10(4):271-85. PubMed ID: 12809357
[TBL] [Abstract][Full Text] [Related]
37. Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects.
Karim A; Tolbert D; Piergies A; Hubbard RC; Harper K; Wallemark CB; Slater M; Geis GS
J Clin Pharmacol; 2000 Jun; 40(6):655-63. PubMed ID: 10868317
[TBL] [Abstract][Full Text] [Related]
38. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Chan E; Hegde A; Chen X
J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
[TBL] [Abstract][Full Text] [Related]
39. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
[TBL] [Abstract][Full Text] [Related]
40. Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats.
Cao YG; Liu XQ; Chen YC; Hao K; Wang GJ
Eur J Pharm Sci; 2007 Feb; 30(2):175-80. PubMed ID: 17169538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
